AI assistant
HARVARD BIOSCIENCE INC — Director's Dealing 2013
Jan 14, 2013
34975_dirs_2013-01-14_6c0e8e7c-fb0a-416e-ac90-716f35e0a632.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: HARVARD BIOSCIENCE INC (HBIO)
CIK: 0001123494
Period of Report: 2013-01-14
Reporting Person: LUSCINSKI SUSAN M (Chief Operating Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2013-01-14 | Common Stock | F | 11475 | $4.38 | Disposed | 426180 | Direct |
Footnotes
F1: The shares were disposed to satisfy Ms. Luscinski's tax withholding obligation in connection with deferred stock awards granted to Ms. Luscinski on June 4, 2010, June 2, 2011 and June 1, 2012 all of which vested in part on January 1, 2013.
F2: Includes (a) a deferred stock award of 16,700 restricted stock units which will vest on Jan1, 2014; (b) a deferred stock award of 9,374 restricted stock units which vest in equal installments on Jan 1, 2014 and Jan 1, 2015; (c) a deferred stock award of 30,954 restricted stock units which vest in equal installments on Jan 1, 2014, Jan 1, 2015 and Jan 1, 2016; and (d) 369,152 shares of common stock held by Ms. Luscinski.